Managing Expectations: Domestic Generics Could Serve As Reference In China Bioequivalence Testing
This article was originally published in PharmAsia News
Executive Summary
On the eve of releasing technical guidelines on bioequivalence testing for generic drugs, Chinese officials have already started lowering expectations by emphasizing uncertainties about testing subject selection and difficulties in obtaining reference products.